Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Testing effectiveness (Phase 2)Looking for participantsNCT07497399
What this trial is testing

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 120
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Testing effectiveness (Phase 2)Study completedNCT06481085
What this trial is testing

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 324
Not applicableNot Yet RecruitingNCT07340112
What this trial is testing

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

Who this might be right for
Peripheral Arterial Disease (PAD)Claudication, IntermittentChronic Limb-Threatening Ischemia
University Hospital, Strasbourg, France 50
Not applicableLooking for participantsNCT06839248
What this trial is testing

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Who this might be right for
Residual Gastric ContentsPulmonary Aspiration of Gastric Contents
St Vincent's Hospital Melbourne 154
Post-approval studies (Phase 4)Study completedNCT02291874
What this trial is testing

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 100
Not applicableLooking for participantsNCT07224880
What this trial is testing

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
glp1 AgonistGene ExpressionSkin Laxity
Cytrellis Biosystems, Inc. 10
Not applicableStudy completedNCT05136287
What this trial is testing

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Quality of Life+1 more
Jose Seijas Amigo 140
Not applicableStudy completedNCT03993132
What this trial is testing

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 26,774
Not applicableActive Not RecruitingNCT07457424
What this trial is testing

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Who this might be right for
Metabolic DiseaseObesity & Overweight
University College Dublin 140
Not applicableStudy completedNCT07269821
What this trial is testing

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

Who this might be right for
GLP-1Weight Loss TrajectoryEmotional Disorder+1 more
University of Alicante 70
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Not applicableLooking for participantsNCT07190794
What this trial is testing

RESCUE: Discontinuation of GLP-1

Who this might be right for
Obesity
Boston Scientific Corporation 150
Large-scale testing (Phase 3)Looking for participantsNCT07193459
What this trial is testing

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360
Very early researchLooking for participantsNCT07012642
What this trial is testing

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Who this might be right for
Lymphedema
Advanced Reconstructive Surgery Alliance 110
Not applicableStudy completedNCT06500143
What this trial is testing

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Who this might be right for
Gastric Retention
Ciusss de L'Est de l'Île de Montréal 94
Early research (Phase 1)Not Yet RecruitingNCT06520540
What this trial is testing

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Who this might be right for
Glucagon-Like Peptide-1 Receptor Agonists
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Post-approval studies (Phase 4)Study completedNCT01744236
What this trial is testing

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 70
Not applicableEnded earlyNCT06273163
What this trial is testing

Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation

Who this might be right for
Obesity
University of Texas Southwestern Medical Center 39
Load More Results